Which feature best distinguishes Type I (pharmacokinetic) drug interactions from Type II (pharmacodynamic) drug interactions?

Question

Accepted Answer

C. Type I involves altered drug metabolism or absorption; Type II involves combined effects at the same receptor or site of action. ## Classification of Drug Interactions

### Type I (Pharmacokinetic) Interactions

**Key Point:** These involve changes in drug absorption, distribution, metabolism, or elimination, leading to altered plasma concentrations of one or both drugs.

1. **Absorption:** Antacids reduce fluoroquinolone absorption
2. **Distribution:** Displacement from protein binding (e.g., warfarin + NSAIDs)
3. **Metabolism:** CYP450 enzyme induction (e.g., rifampicin increases warfarin metabolism) or inhibition (e.g., ketoconazole inhibits CYP3A4)
4. **Elimination:** Reduced renal clearance (e.g., NSAIDs reduce ACE inhibitor elimination)

### Type II (Pharmacodynamic) Interactions

**Key Point:** These occur when two drugs act on the same physiological system or receptor, producing additive, synergistic, or antagonistic effects WITHOUT altering each other's plasma concentration.

1. **Additive effects:** Two CNS depressants (alcohol + benzodiazepines)
2. **Synergistic effects:** ACE inhibitor + potassium-sparing diuretic (both increase K⁺)
3. **Antagonistic effects:** Beta-blocker + salbutamol (opposing effects on β-adrenergic receptors)

### Discriminating Features

| Feature | Type I (Pharmacokinetic) | Type II (Pharmacodynamic) |
| --- | --- | --- |
| **Mechanism** | Altered drug levels (absorption, metabolism, elimination) | Combined effects at same target/receptor |
| **Plasma concentration** | Changed | Unchanged |
| **Onset** | May be delayed (enzyme induction takes days) | Usually rapid |
| **Reversibility** | Reversible after drug withdrawal | Reversible after drug withdrawal |
| **Example** | Rifampicin ↓ warfarin levels | Warfarin + aspirin → ↑ bleeding risk |

**High-Yield:** The **best discriminator** is the site of interaction: Type I affects drug handling (ADME); Type II affects drug action (receptor/site level).

**Clinical Pearl:** A patient on warfarin started on rifampicin (Type I: enzyme induction) will need warfarin dose increase to maintain INR. A patient on warfarin given aspirin (Type II: both inhibit coagulation) will have increased bleeding without any change in warfarin level.

Answer

A. Type I requires enzyme induction; Type II requires enzyme inhibition

Answer

B. Type I occurs only with oral drugs; Type II occurs only with intravenous drugs

Answer

D. Type I is predictable and dose-dependent; Type II is unpredictable and idiosyncratic

Which feature best distinguishes Type I (pharmacokinetic) drug interactions from Type II (pharmacodynamic) drug interactions?

Explanation

Classification of Drug Interactions

Type I (Pharmacokinetic) Interactions

Type II (Pharmacodynamic) Interactions

Discriminating Features

Practice similar questions

Join our NEET PG community

Feature	Type I (Pharmacokinetic)	Type II (Pharmacodynamic)
Mechanism	Altered drug levels (absorption, metabolism, elimination)	Combined effects at same target/receptor
Plasma concentration	Changed	Unchanged
Onset	May be delayed (enzyme induction takes days)	Usually rapid
Reversibility	Reversible after drug withdrawal	Reversible after drug withdrawal
Example	Rifampicin ↓ warfarin levels	Warfarin + aspirin → ↑ bleeding risk